XOMA Royalty Corporation — Company profile
Healthcare · Biotechnology · United States
Last price 40.17 USD (At close: Jul 13, 2026) · Market cap 710.16M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
Details
| Name | XOMA Royalty Corporation |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 14 |
| Founded | 1981 |
| Ceo | Owen Hughes |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US98419J2069 |
| Cusip | 98419J206 |
| Cik | 0000791908 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Owen P. Hughes Jr. | Chief Executive Officer and Director |
| Bradley Sitko | Chief Investment Officer |
| Jeffrey Trigilio | Chief Financial Officer |
| Juliane Snowden | Head of Investor Relations |
| Maricel Perea Montano | Chief Legal Officer and Corporate Secretary |
Contact
| Address | 2200 Powell Street, Suite 310, EmeryVille, California 94608, United States |
| Phone | 510 204 7200 |
| Website | https://www.xoma.com |